Skip to content

Clinical efficacy observation of acupuncture treatment for moderate to severe female stress urinary incontinence

Clinical efficacy observation of acupuncture treatment for moderate to severe female stress urinary incontinence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084772
Enrollment
Unknown
Registered
2024-05-24
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress urinary incontinence

Interventions

Experimental group:the acupoints on the lower abdomen of the Ren meridian Point selection: Guan Yuan, Zhong Ji
Control group:the lumbosacral part of the bladder meridian Point selection: Zhongliao, Huiyang

Sponsors

China Aerospace Science & Industry Corporation 731 Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for female stress urinary incontinence; (2) Age range from 45 to 70 years old; (3) The course of the disease is 5-10 years; (4) 1 hour urine leakage>10g; (5) Voluntarily cooperate with acupuncture treatment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Urgent urinary incontinence, mixed urinary incontinence, and overflow urinary incontinence, etc; (2) History of surgical treatment or pelvic floor surgery for urinary incontinence; (3) Genital prolapse = 2 degrees; (4) Symptomatic urinary tract infection; (5) Residual urine>30ml; (6) Maximum urine flow rate<20ml/s; (7) Individuals who are unable or restricted in walking, going up and down stairs, or running; (8) Continuously using drugs that may affect bladder function or receiving specialized treatment for female stress urinary incontinence; (9) Patients with severe heart, brain, liver, kidney, hematopoietic system and mental disease, diabetes, multiple system atrophy, cauda equina nerve lesion, and myelopathy.

Design outcomes

Primary

MeasureTime frame
1h urine pad test;

Secondary

MeasureTime frame
72-hour urination diary card;patient satisfaction;Patient acceptance;

Countries

China

Contacts

Public ContactHan guanxiong

China Aerospace Science & Industry Corporation 731 Hospital

672289749@qq.com+86 139 3157 0486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026